Healthcare Commissioners' Experience with Antibiotic Resistance During the COVID-19 Pandemic in Saudi Arabia: a Qualitative Study

Overview

Journal J Pharm Policy Pract

Date 2024 Jan 11

PMID 38205192

Authors

Hadi Jaber Al Sulayyim

Rohani Ismail

Abdullah Al Hamid

Noraini Abdul Ghafar

Affiliations

Soon will be listed here.

Abstract

Introduction: The occurrence of antibiotic resistance (AR) has become a critical issue during the Novel coronavirus disease 2019 (COVID-19) pandemic. This study explores the experiences of healthcare commissioners with AR during the COVID-19 pandemic, identifies challenges, and provides recommendations for combating AR during pandemics.

Methods: This qualitative study was multi-centered and used a phenomenological approach. Semi-structured interviews were conducted between December 2022 and January 2023 among 11 health commissioners using video calls.

Results: Seven themes emerged from the data, including knowledge of AR and its consequences, the antibiotic prescription system, the future of AR and potential contributory factors, the impact of COVID-19 on AR and their relationship, the experience of AR during the COVID-19 pandemic in healthcare facilities, barriers that prevent the misuse of antibiotics during pandemics, and recommendations regarding antibiotic resistance during pandemics.

Conclusion: The findings of this study could be used to inform policy and practice for government healthcare workers (HCWs) and the public. Furthermore, this study identified the main challenges of AR during the pandemic, and the recommendations of health commissioners were provided accordingly. Such recommendations could be beneficial on a national and international scale to reduce the impact of future pandemics on AR.

Abbreviations: COVID-19: Novel coronavirus disease 2019; AR: Antibiotic Resistance; IPC: Infection prevention and control; MDRO: multi-drug resistant organism; ASP: Antimicrobial Stewardship Program; HCW: Healthcare worker; KSA: Kingdom of Saudi Arabia; WHO: World Health Organization; MOH: Ministry of Health; MOEWA: Ministry of Environment, Water, and Agriculture; AMR: Antimicrobial Resistance; PHCC: Primary Healthcare Center.

References

Gaspar G, Ferreira L, Feliciano C, Campos Junior C, Molina F, Vendruscolo A . Pre- and post-COVID-19 evaluation of antimicrobial susceptibility for healthcare-associated infections in the intensive care unit of a tertiary hospital. Rev Soc Bras Med Trop. 2021; 54:e00902021. PMC: 8313097. DOI: 10.1590/0037-8682-0090-2021. View

Khojah H . Over-the-counter sale of antibiotics during COVID-19 outbreak by community pharmacies in Saudi Arabia: a simulated client study. BMC Health Serv Res. 2022; 22(1):123. PMC: 8799453. DOI: 10.1186/s12913-022-07553-x. View

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

Nabovati E, Rangraz Jeddi F, Farrahi R, Anvari S . Information technology interventions to improve antibiotic prescribing for patients with acute respiratory infection: a systematic review. Clin Microbiol Infect. 2021; 27(6):838-845. DOI: 10.1016/j.cmi.2021.03.030. View

Walsh T . A one-health approach to antimicrobial resistance. Nat Microbiol. 2018; 3(8):854-855. DOI: 10.1038/s41564-018-0208-5. View

Hawking M, Lecky D, Touboul Lundgren P, Aldigs E, AbdulMajed H, Ioannidou E . Attitudes and behaviours of adolescents towards antibiotics and self-care for respiratory tract infections: a qualitative study. BMJ Open. 2017; 7(5):e015308. PMC: 5734195. DOI: 10.1136/bmjopen-2016-015308. View

Huttner B, Catho G, Pano-Pardo J, Pulcini C, Schouten J . COVID-19: don't neglect antimicrobial stewardship principles!. Clin Microbiol Infect. 2020; 26(7):808-810. PMC: 7190532. DOI: 10.1016/j.cmi.2020.04.024. View

Khan S, Bond S, Bakhit M, Hasan S, Sadeq A, Conway B . COVID-19 Mixed Impact on Hospital Antimicrobial Stewardship Activities: A Qualitative Study in UK-Based Hospitals. Antibiotics (Basel). 2022; 11(11). PMC: 9686587. DOI: 10.3390/antibiotics11111600. View

Van Dort B, Carland J, Penm J, Ritchie A, Baysari M . Digital interventions for antimicrobial prescribing and monitoring: a qualitative meta-synthesis of factors influencing user acceptance. J Am Med Inform Assoc. 2022; 29(10):1786-1796. PMC: 9471701. DOI: 10.1093/jamia/ocac125. View

10.

Sulayyim H, Ismail R, Al Hamid A, Abdul Ghafar N . Antibiotic Resistance during COVID-19: A Systematic Review. Int J Environ Res Public Health. 2022; 19(19). PMC: 9565540. DOI: 10.3390/ijerph191911931. View

11.

Chang Q, Wang W, Regev-Yochay G, Lipsitch M, Hanage W . Antibiotics in agriculture and the risk to human health: how worried should we be?. Evol Appl. 2015; 8(3):240-7. PMC: 4380918. DOI: 10.1111/eva.12185. View

12.

Saleh D, Abu-Farha R, Mukattash T, Barakat M, Alefishat E . Views of Community Pharmacists on Antimicrobial Resistance and Antimicrobial Stewardship in Jordan: A Qualitative Study. Antibiotics (Basel). 2021; 10(4). PMC: 8067308. DOI: 10.3390/antibiotics10040384. View

13.

Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y . Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020; 395(10223):507-513. PMC: 7135076. DOI: 10.1016/S0140-6736(20)30211-7. View

14.

Avent M, Cosgrove S, Price-Haywood E, van Driel M . Antimicrobial stewardship in the primary care setting: from dream to reality?. BMC Fam Pract. 2020; 21(1):134. PMC: 7346425. DOI: 10.1186/s12875-020-01191-0. View

15.

Vaughn V, Gandhi T, Petty L, Patel P, Prescott H, Malani A . Empiric Antibacterial Therapy and Community-onset Bacterial Coinfection in Patients Hospitalized With Coronavirus Disease 2019 (COVID-19): A Multi-hospital Cohort Study. Clin Infect Dis. 2020; 72(10):e533-e541. PMC: 7499526. DOI: 10.1093/cid/ciaa1239. View

16.

Pamplin J, Nemeth C, Serio-Melvin M, Murray S, Rule G, Veinott E . Improving Clinician Decisions and Communication in Critical Care Using Novel Information Technology. Mil Med. 2019; 185(1-2):e254-e261. DOI: 10.1093/milmed/usz151. View

17.

Godman B, Egwuenu A, Haque M, Malande O, Schellack N, Kumar S . Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries. Life (Basel). 2021; 11(6). PMC: 8229985. DOI: 10.3390/life11060528. View

18.

Borek A, Maitland K, Mcleod M, Campbell A, Hayhoe B, Butler C . Impact of the COVID-19 Pandemic on Community Antibiotic Prescribing and Stewardship: A Qualitative Interview Study with General Practitioners in England. Antibiotics (Basel). 2021; 10(12). PMC: 8698307. DOI: 10.3390/antibiotics10121531. View

19.

Comelli A, Genovese C, Lombardi A, Bobbio C, Scudeller L, Restelli U . What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres. Antimicrob Resist Infect Control. 2022; 11(1):108. PMC: 9421115. DOI: 10.1186/s13756-022-01152-5. View

20.

Tosepu R, Gunawan J, Effendy D, Rustam H, Muchtar F, Sakka A . Experience of healthcare workers in combatting COVID-19 in Indonesia: A descriptive qualitative study. Belitung Nurs J. 2023; 7(1):37-42. PMC: 10353590. DOI: 10.33546/bnj.1251. View